Evidence map›Paper›PMID 31256876›Full record

ArticleAmerican journal of human genetics2019

Mutations in PIGB Cause an Inherited GPI Biosynthesis Defect with an Axonal Neuropathy and Metabolic Abnormality in Severe Cases.

Yoshiko Murakami, Thi Tuyet Mai Nguyen, Nissan Baratang, Praveen K Raju, Alexej Knaus, Sian Ellard, Gabriela Jones, Baiba Lace, Justine Rousseau, Norbert Fonya Ajeawung and 35 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Powerful mapping ofmedRxiv : the preprint server for health sciences · 2024
    Article
  8. Observational
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. PIGG variant pathogenicity assessment reveals characteristic features within 19 families.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 10 countries.

Yoshiko MurakamiYabumoto Department of Intractable Disease Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
Thi Tuyet Mai NguyenCentre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Nissan BaratangCentre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Praveen K RajuCentre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Alexej KnausInsitute for Genomic Statistics and Bioinformatics, University Hospital Bonn, 53127 Bonn, Germany.
Sian EllardRoyal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Gabriela JonesClinical Genetics Department, Nottingham University Hospitals NHS Trust, Nottingham NGS 1PB, UK.
Baiba LaceCentre Hospitalier Universitaire de Québec, 2705 Boulevard Laurier, Ville de Québec, QC G1V 4G2, Canada.
Justine RousseauCentre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Norbert Fonya AjeawungCentre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Atsushi KameiDepartment of Pediatrics, School of Medicine, Iwate Medical University, Morioka, Iwate 020-8505, Japan.
Gaku MinaseDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Manami AkasakaDepartment of Pediatrics, School of Medicine, Iwate Medical University, Morioka, Iwate 020-8505, Japan.
Nami ArayaDepartment of Pediatrics, School of Medicine, Iwate Medical University, Morioka, Iwate 020-8505, Japan.
Eriko KoshimizuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Jenneke van den EndeCentrum Medische Genetica Antwerpen, 2650 EDEGEM, Belgium.
Florian ErgerInstitute of Human Genetics, University Hospital of Cologne, and Center for Molecular Medicine, University of Cologne, 50931 Cologne, Germany.
Janine AltmüllerCologne Center for Genomics, University of Cologne, 50931 Cologne, Germany.
Zita KruminaDeparment of Biology and Microbiology, Riga Stradinš University, Riga, LV-1029, Latvia.
Jurgis StrautmanisChildren's Clinical University Hospital, Riga, LV-1004, Latvia.
Inna InashkinaLatvian Biomedical Research and Study Centre, Ratsupites Str. 1 k-1, Riga LV-1067, Latvia.
Janis StavusisLatvian Biomedical Research and Study Centre, Ratsupites Str. 1 k-1, Riga LV-1067, Latvia.
Areeg El-GharbawyDepartment of Medical Genetics, Children's Hospital of Pittsburgh of University Pittsburgh Medical Center, Pittsburgh, PA 15224, USA.
Jessica SebastianDepartment of Medical Genetics, Children's Hospital of Pittsburgh of University Pittsburgh Medical Center, Pittsburgh, PA 15224, USA.
Ratna Dua PuriInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi 110060, India.
Samarth KulshresthaInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi 110060, India.
Ishwar C VermaInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi 110060, India.
Esther M MaierDepartment of Inborn Errors of Metabolism, Dr. von Hauner Children's Hospital, 80337 Munich, Germany.
Tobias B HaackInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72074 Tübingen, Germany; Institute of Human Genetics, Technische Universität München, 81675 Munich, Germany.
Anil IsraniDepartment of Paediatric Neurology, Leicester Royal Infirmary, Leicester LE1 5WW, UK.
Julia BaptistaRoyal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Adam GunningRoyal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Pengfei LiuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Marieke JoostenDept of Clinical Genetics, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, the Netherlands.
María Eugenia RochaCENTOGENE AG, The Rare Disease Company, 18055 Rostock, Germany.
Mais O HashemDepartment of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
Hesham M AldhalaanDepartment of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
Fowzan S AlkurayaDepartment of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Peter M KrawitzInsitute for Genomic Statistics and Bioinformatics, University Hospital Bonn, 53127 Bonn, Germany.
Elsa RossignolCentre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia; Department of Neurosciences, Centre Hospitalier Universitaire Sainte-Justine and University of Montreal, Montreal, QC H3T 1C5, Canada.
Taroh KinoshitaYabumoto Department of Intractable Disease Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. Electronic address: tkinoshi@biken.osaka-u.ac.jp.
Philippe M CampeauCentre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada; Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine and University of Montreal, Montreal, QC H3T 1C5, Canada. Electronic address: p.campeau@umontreal.ca.
Centre Hospitalier Universitaire Sainte-Justine · CAKing Faisal Specialist Hospital & Research Centre · SAYokohama City University · JPIwate Medical University · JPRoyal Devon & Exeter NHS Foundation Trust · GBSir Ganga Ram Hospital · INBaylor College of Medicine · USChildren's Hospital of Pittsburgh · USLatvian Biomedical Research and Study Centre · LVThe University of Osaka · JPUniversity Hospital Bonn · DEUniversity of Cologne · DECentogene (Germany) · DECentre hospitalier universitaire de Québec · CAChildren's Clinical University Hospital · LVErasmus MC · NLInstitute of Human Genetics · PLLeicester Royal Infirmary · GBNottingham University Hospitals NHS Trust · GBRiga Stradiņš University · LV

Funding

CIHR
6 · The paper itself

Abstract

Proteins anchored to the cell surface via glycosylphosphatidylinositol (GPI) play various key roles in the human body, particularly in development and neurogenesis. As such, many developmental disorders are caused by mutations in genes involved in the GPI biosynthesis and remodeling pathway. We describe ten unrelated families with bi-allelic mutations in PIGB, a gene that encodes phosphatidylinositol glycan class B, which transfers the third mannose to the GPI. Ten different PIGB variants were found in these individuals. Flow cytometric analysis of blood cells and fibroblasts from the affected individuals showed decreased cell surface presence of GPI-anchored proteins. Most of the affected individuals have global developmental and/or intellectual delay, all had seizures, two had polymicrogyria, and four had a peripheral neuropathy. Eight children passed away before four years old. Two of them had a clinical diagnosis of DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures), a condition that includes sensorineural deafness, shortened terminal phalanges with small finger and toenails, intellectual disability, and seizures; this condition overlaps with the severe phenotypes associated with inherited GPI deficiency. Most individuals tested showed elevated alkaline phosphatase, which is a characteristic of the inherited GPI deficiency but not DOORS syndrome. It is notable that two severely affected individuals showed 2-oxoglutaric aciduria, which can be seen in DOORS syndrome, suggesting that severe cases of inherited GPI deficiency and DOORS syndrome might share some molecular pathway disruptions.

Indexed as

MutationAdultChildChild, PreschoolCraniofacial AbnormalitiesFemaleGlycosylphosphatidylinositolsHand Deformities, CongenitalHearing Loss, SensorineuralHumansInfantInfant, NewbornIntellectual DisabilityMaleMannosyltransferasesMetabolic DiseasesGlycosylphosphatidylinositolsMannosyltransferasesPIGB protein, humanalkaline phosphataseDOORS syndromeepilepsyglycosylphosphatidylinositolinherited GPI deficiency (IGD)intellectual disabilityneuropathyPIGBseizures

Identifiers

PMID31256876
PMCPMC6698938
OpenAlexW2954324461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.